US President Donald Trump has signed a new order imposing tariffs on pharmaceuticals, potentially reaching 100%, amid national security concerns. This move could significantly impact global supply chains and prices.

Donald Trump unveiled sweeping new pharmaceutical tariffs on Thursday that could reach 100% unless drugmakers strike pricing deals with his administration. The move, tied to national security concerns, escalates his trade strategy and could reshape global supply chains and raise costs.